LT3169307T - Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną - Google Patents

Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Info

Publication number
LT3169307T
LT3169307T LTEP15738918.0T LT15738918T LT3169307T LT 3169307 T LT3169307 T LT 3169307T LT 15738918 T LT15738918 T LT 15738918T LT 3169307 T LT3169307 T LT 3169307T
Authority
LT
Lithuania
Prior art keywords
ibuprophene
aqueous composition
composition including
including paracetamol
paracetamol
Prior art date
Application number
LTEP15738918.0T
Other languages
English (en)
Inventor
Thomas Jacobsen
Original Assignee
Hyloris Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyloris Pharmaceuticals SA filed Critical Hyloris Pharmaceuticals SA
Publication of LT3169307T publication Critical patent/LT3169307T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
LTEP15738918.0T 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną LT3169307T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen
PCT/EP2015/066466 WO2016009067A1 (en) 2014-07-18 2015-07-17 Aqueous formulation comprising paracetamol and ibuprofen

Publications (1)

Publication Number Publication Date
LT3169307T true LT3169307T (lt) 2020-07-10

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP15738918.0T LT3169307T (lt) 2014-07-18 2015-07-17 Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną

Country Status (26)

Country Link
US (5) US11219609B2 (lt)
EP (2) EP3656377B1 (lt)
JP (2) JP6745798B2 (lt)
CN (2) CN113018258A (lt)
AR (1) AR100365A1 (lt)
AU (1) AU2015289035B2 (lt)
BR (1) BR112017001093B1 (lt)
CA (1) CA2955557C (lt)
CY (1) CY1122899T1 (lt)
DK (1) DK3169307T3 (lt)
EA (1) EA036212B1 (lt)
ES (2) ES3013411T3 (lt)
HR (1) HRP20200704T1 (lt)
HU (1) HUE048881T2 (lt)
IL (1) IL250112B2 (lt)
LT (1) LT3169307T (lt)
MX (1) MX381776B (lt)
MY (1) MY192813A (lt)
NZ (1) NZ728796A (lt)
PL (2) PL3656377T3 (lt)
PT (1) PT3169307T (lt)
RS (1) RS60289B1 (lt)
SG (1) SG11201700421RA (lt)
SI (1) SI3169307T1 (lt)
TN (1) TN2017000011A1 (lt)
WO (2) WO2016008546A1 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018025128A1 (en) * 2016-08-02 2018-02-08 Jamil Irfan Stable ibuprofen injectable composition
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) * 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
EP4329733A1 (en) * 2021-04-28 2024-03-06 Haleon US IP LLC Alkali metal salt combinations of incompatible active pharmaceutical ingredients
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση
IL324832A (en) 2023-06-02 2026-01-01 Ioulia Tseti Pharmaceutical composition comprising ibuprofen
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
WO2026132842A1 (en) * 2024-12-18 2026-06-25 Ioulia Tseti Pre-filled syringe of aqueous solution of paracetamol and/or ibuprofen suitable for injectable administration
GR1011104B (el) * 2024-12-18 2026-01-16 Ιουλια Τσετη Προγεμισμενη συριγγα υδατικου διαλυματος παρακεταμολης καταλληλη για ενεσιμη χορηγηση
US20260174715A1 (en) * 2024-12-24 2026-06-25 Hikma Pharmaceuticals Usa Inc. Formulations for injectable combination product containing acetaminophen and ibuprofen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
KR20110065417A (ko) 2008-01-03 2011-06-15 욱크하르트 리미티드 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
TR201906742T4 (tr) 2008-10-14 2019-05-21 Aft Pharmaceuticals Ltd Tıbbi bir ürün ve tedavi.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PT2389923E (pt) * 2010-05-19 2013-03-28 Uni Pharma Kleon Tsetis Pharmaceutical Lab S A Formulação injectável estável de paracetamol pronta a usar
ES2742373T3 (es) * 2010-11-04 2020-02-14 Aft Pharmaceuticals Ltd Una composición de combinación
BE1020614A5 (nl) 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
PE20150083A1 (es) * 2012-03-16 2015-01-21 Cumberland Pharmaceuticals Inc Formulacion de ibuprofeno inyectable
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
AU2015289035B2 (en) 2020-03-26
JP6745798B2 (ja) 2020-08-26
PT3169307T (pt) 2020-05-18
EA201790223A1 (ru) 2017-05-31
MX2017000764A (es) 2017-08-18
ES2791349T3 (es) 2020-11-04
IL250112B2 (en) 2023-02-01
WO2016009067A1 (en) 2016-01-21
US11389416B2 (en) 2022-07-19
DK3169307T3 (da) 2020-05-11
US20190343785A1 (en) 2019-11-14
NZ728796A (en) 2023-05-26
JP2017522382A (ja) 2017-08-10
CA2955557A1 (en) 2016-01-21
EP3656377A1 (en) 2020-05-27
EP3656377B1 (en) 2025-02-12
CN106794163A (zh) 2017-05-31
JP2020059740A (ja) 2020-04-16
US20250064764A1 (en) 2025-02-27
WO2016008546A1 (en) 2016-01-21
HUE048881T2 (hu) 2020-08-28
AR100365A1 (es) 2016-09-28
BR112017001093A2 (pt) 2017-11-14
TN2017000011A1 (en) 2018-07-04
PL3169307T3 (pl) 2020-09-21
CA2955557C (en) 2021-06-22
EP3169307A1 (en) 2017-05-24
US11219609B2 (en) 2022-01-11
IL250112B (en) 2022-10-01
CN113018258A (zh) 2021-06-25
BR112017001093B1 (pt) 2023-01-31
EA036212B1 (ru) 2020-10-14
MY192813A (en) 2022-09-09
ES3013411T3 (en) 2025-04-11
SG11201700421RA (en) 2017-02-27
MX381776B (es) 2025-03-13
US11213498B2 (en) 2022-01-04
US12083087B2 (en) 2024-09-10
EP3656377C0 (en) 2025-02-12
AU2015289035A1 (en) 2017-02-23
PL3656377T3 (pl) 2025-05-26
RS60289B1 (sr) 2020-07-31
US20220031645A1 (en) 2022-02-03
EP3169307B1 (en) 2020-02-19
IL250112A0 (en) 2017-03-30
US20170209398A1 (en) 2017-07-27
CN106794163B (zh) 2021-03-26
US20230181502A1 (en) 2023-06-15
JP6892494B2 (ja) 2021-06-23
CY1122899T1 (el) 2021-05-05
SI3169307T1 (sl) 2020-07-31
HRP20200704T1 (hr) 2020-07-24

Similar Documents

Publication Publication Date Title
IL304772A (en) Antibodies, uses and methods
NO2023013I1 (no) Combination of foslevodopa and foscarbidopa, each in all forms protected by the basic patent
DK3587417T3 (da) 1,3-thiazol-2-yl-substituerede benzamider
LT3221306T (lt) Heteroarilo junginiai, kaip irak inhibitoriai ir jų panaudojimas
LT3317284T (lt) Benzoksazepino oksazolidinono junginiai ir jų naudojimo būdai
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
HRP20260361T1 (hr) Supstituirani 4-fenilpiperidini, njihova priprava i uporaba
LT3240895T (lt) Kompozicijos ir būdai, skirti baltymų glikozilinimui
LT3128005T (lt) Sirp-alfa varianto konstruktai, ir jų panaudojimas
LT3265123T (lt) Antikūnai, naudojimas ir būdai
IL250112B (en) Aqueous formulation comprising paracetamol and ibuprofen
FR3023988B3 (fr) .
LT3347006T (lt) Deuterinti etifoksino analogai, jų dariniai ir panaudojimai
LT3337506T (lt) Deriniai ir jų panaudojimas
FR3023171B1 (fr) Autoinjecteur.
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3223796T3 (da) Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
IL259234B (en) Cephem compounds, their production and use
LT3216451T (lt) Oftalmologinė vandeninė kompozicija
PL3166945T3 (pl) Nowe pochodne triazolopirymidynonu lub triazolopirydynonu i ich zastosowanie
DK3166473T3 (da) Oftalmoskoper
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
LT3247711T (lt) Naujos scy-078 druskos ir polimorfai
FR3023170B1 (fr) Autoinjecteur.
BR112016025075A2 (pt) formulação agroquímica.